Charles S. Grob, M.D, endorses Healthcare Practitioner Access to Psilocybin for Professional Training - TheraPsil

This page focuses on TheraPsil’s advocacy for healthcare practitioner access to psilocybin as part of professional training in psilocybin-assisted psychotherapy. It explains TheraPsil’s view that experiential learning can help therapists better understand the altered state of consciousness patients may encounter during treatment. The page includes a public letter of support from Charles S. Grob, M.D., who states that psychotherapists approved to conduct psychedelic treatment should be allowed to have psychedelic experiences themselves. His letter describes his background in psychedelic research and references work with MDMA, ayahuasca, and psilocybin. The content is aimed at healthcare professionals, psychotherapists, and others interested in training for psychedelic-assisted care. It also references TheraPsil’s broader training efforts and the need for qualified practitioners to support patients seeking psilocybin therapy.